Published in Br J Obstet Gynaecol on September 01, 1980
Excretion of sotalol in breast milk. Br J Clin Pharmacol (1990) 0.82
Oxprenolol placental transfer, plasma concentrations in newborns and passage into breast milk. Br J Clin Pharmacol (1984) 0.75
Echocardiography in chronic heart failure in the community. Q J Med (1993) 7.64
Primary non-compliance with prescribed medication in primary care. BMJ (1993) 6.80
Comparison of the effects of I.C.I. 50172 and propranolol on the cardiovascular responses to adrenaline, isoprenaline and exercise. Br J Pharmacol (1968) 4.20
Consistent cytotoxic-T-lymphocyte targeting of immunodominant regions in human immunodeficiency virus across multiple ethnicities. J Virol (2004) 4.12
Association of road-traffic accidents with benzodiazepine use. Lancet (1998) 4.01
Clinical pharmacologic observations on atenolol, a beta-adrenoceptor blocker. Clin Pharmacol Ther (1976) 3.16
The assessment of beta-adrenoceptor blocking drugs in man. Br J Clin Pharmacol (1977) 3.13
The cardio-toxicity of isoprenaline during hypoxia. Br J Pharmacol (1969) 2.94
Controlled trial of propranolol in thyrotoxicosis. Lancet (1969) 2.54
Antidepressant drug use in primary care: a record linkage study in Tayside, Scotland. BMJ (1996) 2.51
Fusion protein of the paramyxovirus SV5: destabilizing and stabilizing mutants of fusion activation. Virology (2000) 2.39
Association of upper gastrointestinal toxicity of non-steroidal anti-inflammatory drugs with continued exposure: cohort study. BMJ (1997) 2.39
Mobile coronary care and community mortality from myocardial infarction. Lancet (1985) 2.27
Introducing a drug formulary to general practice--effects on practice prescribing costs. J R Coll Gen Pract (1987) 2.24
Beta-adrenoceptor responses to inhaled salbutamol in normal subjects. Eur J Clin Pharmacol (1989) 2.06
Chronic Q fever endocarditis. Br Heart J (1980) 2.03
Non-steroidal anti-inflammatory drugs are associated with emergency admission to hospital for colitis due to inflammatory bowel disease. Gut (1997) 1.98
The clinical pharmacology of beta adrenergic blocking drugs. J R Coll Physicians Lond (1976) 1.94
A double-blind placebo-controlled trial of theophylline in general practice. Br J Clin Pract (1991) 1.93
Pharmacokinetics, efficacy and adverse effects of sublingual salbutamol in patients with asthma. Eur J Clin Pharmacol (1989) 1.88
Bronchodilator subsensitivity after chronic dosing with eformoterol in patients with asthma. Am J Med (1994) 1.86
Is maintenance digoxin necessary in patients with sinus rhythm? Lancet (1979) 1.86
Blood levels of practolol after oral and parenteral administration and their relationship to exercise heart rate. Clin Pharmacol Ther (1974) 1.81
Influence of intrinsic sympathomimetic activity and cardioselectivity on beta adrenoceptor blockade. Clin Pharmacol Ther (1977) 1.77
Observations on the efficacy and pharmacokinetics of sotalol after oral administration. Eur J Clin Pharmacol (1976) 1.71
Validation of observed differences in the utilization of antihypertensive and antidiabetic drugs in Northern Ireland, Norway and Sweden. Eur J Clin Pharmacol (1985) 1.67
An epidemiological study of digoxin prescribing in general practice. J R Coll Gen Pract (1986) 1.66
Simultaneous measurement of cardiac output and its distribution with microspheres in the rat. Cardiovasc Res (1976) 1.66
Effects of the beta 2-adrenoceptor antagonist ICI 118,551 on exercise tachycardia and isoprenaline-induced beta-adrenoceptor responses in man. Br J Clin Pharmacol (1985) 1.65
Propranolol and the utilization of radioiodine by the human thyroid gland. Acta Endocrinol (Copenh) (1969) 1.63
Plasma binding and the affinity of propranolol for a beta receptor in man. Clin Pharmacol Ther (1976) 1.62
Comparison of the activity and plasma levels of oxprenolol, slow release oxprenolol, long acting propranolol and sotalol. Eur J Clin Pharmacol (1980) 1.57
Comparison of the efficacy and pharmacokinetics of conventional propranolol and a long acting preparation of propranolol. Br J Clin Pharmacol (1980) 1.55
Single dosing comparison of the relative cardiac beta 1/beta 2 activity of inhaled fenoterol and salbutamol in normal subjects. Thorax (1993) 1.51
beta-Adrenoceptor antagonists and respiratory function. Br J Clin Pharmacol (1978) 1.50
Assessment of airways, tremor and chronotropic responses to inhaled salbutamol in the quantification of beta 2-adrenoceptor blockade. Br J Clin Pharmacol (1989) 1.48
Plasma digoxin concentrations in patients on admission to hospital. Br Heart J (1974) 1.46
Adverse reactions and interactions with beta-adrenoceptor blocking drugs. Med Toxicol (1987) 1.44
Contribution of the vagus to the haemodynamic responses following intravenous boluses of isoprenaline. Br J Clin Pharmacol (1983) 1.44
Digoxin compliance in patients from general practice. Br J Clin Pharmacol (1978) 1.38
A clinical evaluation of the maternal effects of lumbar extradural analgesia for labour. Anaesthesia (1974) 1.37
Comparison of the extrapulmonary beta2-adrenoceptor responses and pharmacokinetics of salbutamol given by standard metered dose-inhaler and modified actuator device. Br J Clin Pharmacol (1993) 1.37
Plasma concentrations and the time-course of beta blockade due to propranolol. Clin Pharmacol Ther (1975) 1.36
Brucellosis in Northern Ireland. A serological survey. J Hyg (Lond) (1969) 1.34
Duration of action of beta-blocking drugs. Br Med J (1973) 1.33
Direct determination of the membrane affinities of individual amino acids. Biochemistry (1996) 1.32
The efficacy of orally administered theophylline, inhaled salbutamol, and a combination of the two as chronic therapy in the management of chronic bronchitis with reversible air-flow obstruction. Am Rev Respir Dis (1985) 1.31
Measurement of theophylline in plasma by high performance liquid chromatography. Br J Clin Pharmacol (1976) 1.31
Beta-adrenoceptor responses to high doses of inhaled salbutamol in patients with bronchial asthma. Br J Clin Pharmacol (1988) 1.31
Gastrointestinal events in patients prescribed non-steroidal anti-inflammatory drugs: a controlled study using record linkage in Tayside. Q J Med (1989) 1.31
Phaeochromocytoma in pregnancy. Five cases and a review of the literature. Br J Obstet Gynaecol (1989) 1.31
Investigation of diurnal changes in the disposition of theophylline. Br J Clin Pharmacol (1983) 1.29
Systemic beta-adrenoceptor responses to salbutamol given by metered-dose inhaler alone and with pear shaped spacer attachment: comparison of electrocardiographic, hypokalaemic and haemodynamic effects. Br J Clin Pharmacol (1989) 1.29
The ectodomain of HA2 of influenza virus promotes rapid pH dependent membrane fusion. J Mol Biol (1999) 1.25
Effects on exercise tachycardia during forty-eight hours of a series of doses of atenolol, sotalol, and metoprolol. Clin Pharmacol Ther (1981) 1.23
Central effects of beta-adrenoceptor antagonists. Clin Pharmacol Ther (1983) 1.22
Non-steroidal anti-inflammatory drugs and hospitalization for acute renal failure. QJM (1995) 1.21
Evaluation of the metabolic responses to inhaled salbutamol in the measurement of beta 2-adrenoceptor blockade. Eur J Clin Pharmacol (1989) 1.21
Sex differences in hypokalaemic and electrocardiographic effects of inhaled terbutaline. Thorax (1992) 1.21
Tachyphylaxis to systemic but not to airway responses during prolonged therapy with high dose inhaled salbutamol in asthmatics. Am Rev Respir Dis (1989) 1.20
Plasma theophylline concentrations following the oral administration of microcrystalline theophylline and a new sustained-release theophylline preparation to normal subjects. Eur J Clin Pharmacol (1980) 1.20
Heart rate and blood pressure responses to intravenous boluses of isoprenaline in the presence of propranolol, practolol and atropine. Br J Clin Pharmacol (1983) 1.19
Central effects of beta-adrenoceptor antagonists. I--Performance and subjective assessments of mood. Br J Clin Pharmacol (1988) 1.19
Subsensitivity of bronchodilator and systemic beta 2 adrenoceptor responses after regular twice daily treatment with eformoterol dry powder in asthmatic patients. Thorax (1995) 1.19
A dose-ranging study to evaluate the beta 1-adrenoceptor selectivity of bisoprolol. Eur J Clin Pharmacol (1991) 1.17
Central effects of beta-adrenoceptor antagonists. II--Electroencephalogram and body sway. Br J Clin Pharmacol (1988) 1.17
Adrenoceptor blocking drugs: clinical pharmacology and therapeutic use. Drugs (1979) 1.17
Circadian variation in plasma theophylline concentrations during maintenance therapy with a sustained-release preparation in patients with obstructive airways disease. Br J Clin Pharmacol (1984) 1.15
Correlation of reduction of exercise heart rate with blood levels of atenolol after oral and intravenous administration. Postgrad Med J (1977) 1.13
Comparison of the relative airways and systemic potencies of inhaled fenoterol and salbutamol in asthmatic patients. Thorax (1995) 1.12
A randomised interventional trial of omega-3-polyunsaturated fatty acids on endothelial function and disease activity in systemic lupus erythematosus. Ann Rheum Dis (2007) 1.12
Vagal activity is increased during intravenous isoprenaline infusion in man. Br J Clin Pharmacol (1984) 1.11
Comparative trial of propranolol and practolol in hyperthyroidism. Br J Clin Pharmacol (1975) 1.11
The role of the thyroid in the control of heart-rate. Lancet (1968) 1.10
General practitioners' use of non-steroidal anti-inflammatory drugs in Tayside and Fife regions. J R Soc Med (1992) 1.10
A comparison of verapamil and digoxin in the treatment of atrial fibrillation. Eur Heart J (1987) 1.10
Pharmacokinetics of praziquantel in healthy volunteers and patients with schistosomiasis. Trans R Soc Trop Med Hyg (1991) 1.08
The effects of captopril on the acute vascular responses to frusemide in man. Clin Sci (Lond) (1983) 1.08
Digoxin withdrawal after cardiac failure in patients with sinus rhythm. J Cardiovasc Pharmacol (1983) 1.07
Propranolol in the treatment of thyrotoxicosis: a review. Postgrad Med J (1976) 1.07
Central effects of single oral doses of propranolol in man. Br J Clin Pharmacol (1984) 1.07
The relevance of the anti-human globulin (Coombs) test and the complement-fixation test in the diagnosis of brucellosis. J Hyg (Lond) (1970) 1.07
Suppression of ventricular ectopic depolarizations by tocainide. Circulation (1977) 1.06
Do patients take digoxin? Br Heart J (1978) 1.06
Lupus-like syndrome induced by procainamide. Br Med J (1967) 1.05
An assessment of physiological finger tremor as an indicator of beta-adrenoceptor function. Br J Clin Pharmacol (1983) 1.05
Subsensitivity of beta-adrenoceptor responses in asthmatic patients taking regular low dose inhaled salbutamol. Eur J Clin Pharmacol (1990) 1.03
Enhancement of physiological finger tremor by intravenous isoprenaline infusions in man: evaluation of its role in the assessment of beta-adrenoceptor antagonists. Br J Clin Pharmacol (1984) 1.03
Selectivity of antagonist and partial agonist activity of celiprolol in normal subjects. Br J Clin Pharmacol (1992) 1.03
The risks of symptomatic vaginal candidiasis after oral antibiotic therapy. Q J Med (1993) 1.03
Comparison of the effects of prolonged treatment with low and high doses of inhaled terbutaline on beta-adrenoceptor responsiveness in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis (1990) 1.02
Does the frequency of daily dosage influence compliance with digoxin therapy? Br J Clin Pharmacol (1981) 1.02
Gene probe analysis in an informative family with multiple endocrine neoplasia syndrome type 2A (MEN 2A). Improvement in carrier risk estimation. Q J Med (1991) 1.02
Comparison of hypokalaemic, electrocardiographic and haemodynamic responses to inhaled isoprenaline and salbutamol in young and elderly subjects. Eur J Clin Pharmacol (1991) 1.02
Beta-adrenoceptor blocking drugs and partial agonist activity. Is it clinically relevant? Drugs (1983) 1.01
Observation on the efficacy and pharmacokinetics of betaxolol (SL 75212), a cardioselective beta-adrenoceptor blocking drug. Br J Clin Pharmacol (1981) 1.00